After pulling back sharply from its 52-week high, Rocket Lab (NASDAQ: RKLB) appears to be carving out a meaningful support zone.
Shares are down nearly 30% from their record highs, pressured by February’s broader risk-off rotation in growth stocks and lingering concerns tied to a Neutron development setback earlier this year. Sentiment shifted quickly when the company disclosed a Stage 1 tank rupture during routine hydrostatic pressure testing in January, ultimately pushing the timeline for Neutron’s maiden flight further out.
